BioRestorative Therapies Statistics
Total Valuation
BRTX has a market cap or net worth of $7.08 million. The enterprise value is $4.35 million.
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BRTX has 25.48 million shares outstanding. The number of shares has increased by 15.83% in one year.
| Current Share Class | 25.48M |
| Shares Outstanding | 25.48M |
| Shares Change (YoY) | +15.83% |
| Shares Change (QoQ) | +6.91% |
| Owned by Insiders (%) | 3.24% |
| Owned by Institutions (%) | 11.68% |
| Float | 24.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.19 |
| Forward PS | 3.75 |
| PB Ratio | 7.38 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.84, with a Debt / Equity ratio of 0.12.
| Current Ratio | 0.84 |
| Quick Ratio | 0.80 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -320.47% and return on invested capital (ROIC) is -219.01%.
| Return on Equity (ROE) | -320.47% |
| Return on Assets (ROA) | -119.56% |
| Return on Invested Capital (ROIC) | -219.01% |
| Return on Capital Employed (ROCE) | -4,386.10% |
| Weighted Average Cost of Capital (WACC) | 6.45% |
| Revenue Per Employee | $32,700 |
| Profits Per Employee | -$1.29M |
| Employee Count | 11 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.38% in the last 52 weeks. The beta is 0.41, so BRTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | -84.38% |
| 50-Day Moving Average | 0.49 |
| 200-Day Moving Average | 1.19 |
| Relative Strength Index (RSI) | 41.53 |
| Average Volume (20 Days) | 11,124,927 |
Short Selling Information
The latest short interest is 1.32 million, so 5.17% of the outstanding shares have been sold short.
| Short Interest | 1.32M |
| Short Previous Month | 787,086 |
| Short % of Shares Out | 5.17% |
| Short % of Float | 5.45% |
| Short Ratio (days to cover) | 0.05 |
Income Statement
In the last 12 months, BRTX had revenue of $359,700 and -$14.24 million in losses. Loss per share was -$1.58.
| Revenue | 359,700 |
| Gross Profit | 335,856 |
| Operating Income | -15.65M |
| Pretax Income | -14.24M |
| Net Income | -14.24M |
| EBITDA | -15.44M |
| EBIT | -15.65M |
| Loss Per Share | -$1.58 |
Full Income StatementBalance Sheet
The company has $2.95 million in cash and $42,282 in debt, with a net cash position of $2.91 million or $0.11 per share.
| Cash & Cash Equivalents | 2.95M |
| Total Debt | 42,282 |
| Net Cash | 2.91M |
| Net Cash Per Share | $0.11 |
| Equity (Book Value) | 356,744 |
| Book Value Per Share | 0.04 |
| Working Capital | -586,029 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.79 million and capital expenditures -$116,069, giving a free cash flow of -$10.91 million.
| Operating Cash Flow | -10.79M |
| Capital Expenditures | -116,069 |
| Depreciation & Amortization | 209,985 |
| Net Borrowing | n/a |
| Free Cash Flow | -10.91M |
| FCF Per Share | -$0.43 |
Full Cash Flow StatementMargins
| Gross Margin | 93.37% |
| Operating Margin | -4,350.05% |
| Pretax Margin | -3,959.40% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.83% |
| Shareholder Yield | -15.83% |
| Earnings Yield | -196.14% |
| FCF Yield | -150.18% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | 230.92% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 27, 2021. It was a reverse split with a ratio of 1:4,000.
| Last Split Date | Oct 27, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:4,000 |
Scores
BRTX has an Altman Z-Score of -69.04 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -69.04 |
| Piotroski F-Score | 3 |
